* **Principal Financial Group Inc. Reduced its Stake:** Principal Financial Group Inc. decreased its ownership in Boston Scientific by 1.7% during the second quarter. This signifies a shift in their investment strategy, potentially reflecting a change in their outlook on the company’s future prospects. * **Significant Shareholding:** Principal Financial Group Inc.

These ratios indicate that Boston Scientific is financially sound and well-positioned to handle short-term and long-term obligations. The company’s strong financial position is further supported by its consistent revenue growth, which has averaged 10% over the past five years. This growth is driven by the company’s focus on innovation and expansion into new markets.

MedSurg focuses on products for the treatment of urology, gastroenterology, and general surgery. Cardiovascular focuses on products for the interventional cardiology, peripheral vascular disease, and electrophysiology. The company’s history dates back to 1980, with its founding in the United States. It has a strong global presence, with operations in over 100 countries.